Saturday, October 23News That Matters
Shadow

Tag: XLRN

After-hours buzz: MRK, XLRN & more

After-hours buzz: MRK, XLRN & more

Finance
Check out which companies are making headlines after the bell: Shares of Merck fell more than 2 percent during after-hours trading following a pause in enrollment for two studies of Keytruda, its drug to treat multiple myeloma, due to an imbalance in patient deaths. Multiple myeloma is a cancer of plasma cells, the white blood cells responsible for producing antibodies. Merck said in a statement that the studies have been paused to "allow for additional information to be collected" to understand the multiple deaths. Science Applications International shares tanked more than 12 percent during extended trading after the company reported mixed results for its fiscal first-quarter. Science Applications reported earnings of $ 1.08 per share on revenue of $ 1.1 billion while Wall Street expected...